Eng J, Kleinman WA, Singh L, Singh G, and Raufman JP
In one double-blind, parallel-group, randomized, placebo-controlled trial, semaglutide was assessed as a weight-loss therapy in children 12-18 years of age with obesity (BMI in the 95 th percentile or higher) or who were overweight (BMI in the 85 th percentile or higher) but who had at least one comorbid condition related to their weight
Raj Dasgupta, MD, FACP, FCCP, FAASM, board-certified in pulmonary, sleep, internal, and critical care medicine and chief medical advisor for Sleepopolis, isnt prescribing GLP-1s, but he will refer OSA patients to an endocrinologist if he believes they might benefit from a GLP-1
We know its coming down the pipeline
The ability to avoid needles, and to eat and drink without restrictions, should make this new GLP-1 pill an appealing option to some patients who cant take the injected GLP-1 drugs, says Marilyn Tan, MD, a clinical associate professor and endocrinologist at the Stanford University School of Medicine in California
La edad media de la poblacin estudiada fue de 46,7 aos y el 79,9 % se identific como mujer
